Juncture Wealth Strategies’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.5M Buy
9,559
+7,824
+451% +$2.01M 0.64% 36
2026
Q2
$437K Sell
1,735
-24
-1% -$5.16K 0.11% 121
2026
Q1
$383K Sell
1,759
-15
-0.8% -$3.33K 0.13% 88
2025
Q4
$405K Sell
1,774
-88
-5% -$20K 0.13% 83
2025
Q3
$431K Buy
+1,862
New +$379K 0.14% 83

Other funds holding ABBV

Juncture Wealth Strategies's ABBV Position: Q3 2026 in Review

Juncture Wealth Strategies increased its AbbVie (ABBV) stake by 451% in Q3 2026, buying an estimated $2.01M and bringing the position to 9,559 shares worth $2.5M. The position accounts for 0.64% of the portfolio, ranked #36.

Juncture Wealth Strategies first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Juncture Wealth Strategies held 9,559 shares of AbbVie worth $2.5M as of Q3 2026.
  • Juncture Wealth Strategies bought 7,824 AbbVie shares in Q3 2026, an estimated $2.01M.
  • AbbVie made up 0.64% of Juncture Wealth Strategies's portfolio in Q3 2026, its #36 holding.
  • Juncture Wealth Strategies first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Juncture Wealth Strategies's 13F filing for Q3 2026, filed 6 Oct 2026.